Researchers suggest modulating intestinal microbiota or antigen-presenting activity of IECs represents new approaches to treating autoimmune neurological disease.

The data showed that roughly 65% of the cells in the oxygenated devices remained viable compared to roughly 20% in control devices.

GEN Live panelists will explore how stem cells are transforming disease modeling, drug discovery, and personalized medicine with perspectives on clinical trial progress and hurdles such as ...

Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.

Many organizations still lack structured media optimization and alignment between development and manufacturing, according to Lonza.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.